tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2021 Nov 10;28(1).
doi: 10.3201/eid2801.210917. Online ahead of print.
Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
Maria Skaalum Petersen, Marin Strøm, Jógvan Páll Fjallsbak, Jóhanna Ljósá Hansen, Sólrun Larsen, Eina H Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, Pál Weihe
Abstract
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
Keywords: COVID-19; Faroe Islands; SARS; SARS-CoV-2; coronavirus; coronavirus disease; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2021 Nov 10;28(1).
doi: 10.3201/eid2801.210917. Online ahead of print.
Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
Maria Skaalum Petersen, Marin Strøm, Jógvan Páll Fjallsbak, Jóhanna Ljósá Hansen, Sólrun Larsen, Eina H Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, Pál Weihe
- PMID: 34757895
- DOI: 10.3201/eid2801.210917
Abstract
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
Keywords: COVID-19; Faroe Islands; SARS; SARS-CoV-2; coronavirus; coronavirus disease; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.